These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21621826)

  • 1. Acquired factor VIII inhibitor as presentation of chronic myelogenous leukemia during interferon-alpha therapy.
    Zheng WL; Zhang GS; Shen JK; Pei MF; Peng HL; Xu M
    Thromb Res; 2011 Aug; 128(2):202-3. PubMed ID: 21621826
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatal bone marrow aplasia during interferon-a treatment in chronic myelogenous leukemia.
    Chiusolo P; Sica S; Laurenti L; Piccirillo N; Giordano G; Leone G
    Haematologica; 2000 Feb; 85(2):212. PubMed ID: 10681733
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic sarcoidosis associated with interferon-alpha treatment for chronic myelogenous leukemia.
    Fiorani C; Sacchi S; Bonacorsi G; Cosenza M
    Haematologica; 2000 Sep; 85(9):1006-7. PubMed ID: 10980653
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful pregnancy occurring with interferon-alpha therapy in chronic myeloid leukemia.
    Mesquita MM; Pestana A; Mota A
    Acta Obstet Gynecol Scand; 2005 Mar; 84(3):300-1. PubMed ID: 15715542
    [No Abstract]   [Full Text] [Related]  

  • 5. Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.
    Hughes TP; Kaeda J; Branford S; Rudzki Z; Hochhaus A; Hensley ML; Gathmann I; Bolton AE; van Hoomissen IC; Goldman JM; Radich JP;
    N Engl J Med; 2003 Oct; 349(15):1423-32. PubMed ID: 14534335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of chronic myeloid leukemia with interferon-alpha].
    Szomor A; Molnár L; Nagy A; Dávid M; Alizadeh H; Kecskés M; Vidra T; Kereskai L; Pajor L; Losonczy H
    Orv Hetil; 2000 Nov; 141(48):2601-4. PubMed ID: 11141958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term culture.
    Schultheis B; Heissig B; Pasternak G; Hörner S; Hehlmann R
    Folia Biol (Praha); 2000; 46(6):251-5. PubMed ID: 11140858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Marked reduction of BCR-ABL fusion chromosome positive cells with interferon therapy combined with short-term imatinib in chronic myelogenous leukemia].
    Ajima A; Takayama N; Hasegawa Y; Kojima H; Nagasawa T
    Gan To Kagaku Ryoho; 2003 Nov; 30(12):1997-9. PubMed ID: 14650975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotic syndrome associated with alpha interferon therapy in chronic myeloid leukemia.
    Budak-Alpdoğan T; Lawrence RA; Bayik M; Akoğlu E
    Clin Nephrol; 1997 Jul; 48(1):59-60. PubMed ID: 9247783
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature.
    Bremer CT; Lastrapes A; Alper AB; Mudad R
    Am J Clin Oncol; 2003 Jun; 26(3):262-4. PubMed ID: 12796597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis exacerbated by interferon-alpha in a patient with chronic myeloid leukemia.
    Ladoyanni E; Nambi R
    J Drugs Dermatol; 2005; 4(2):221-2. PubMed ID: 15776781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of alpha-interferon therapy in chronic myeloid leukemia].
    Udvardy M
    Orv Hetil; 2000 Jan; 141(2):67-70. PubMed ID: 10686779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-alpha induced autoimmune hepatitis in a patient with Philadelphia chromosome-positive chronic myeloid leukemia with cytogenetically normal T lymphocytes.
    Ariad S; Song E; Cohen R; Bezwoda WR
    Mol Biother; 1992 Sep; 4(3):139-42. PubMed ID: 1445668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment with interferon alpha of the lymphoblastic transformation of chronic myeloid leukemia].
    Canales MA; Martínez J; Quevedo E; Hernández-Navarro F
    Sangre (Barc); 1999 Dec; 44(6):493-4. PubMed ID: 10822770
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effectiveness of treatment with native alpha-interferon (Wellferon) in patients with chronic myeloid leukemia].
    Rukavitsyn OA
    Vopr Onkol; 1997; 43(6):606-9. PubMed ID: 9479361
    [No Abstract]   [Full Text] [Related]  

  • 16. Interferon-alpha therapy for chronic myeloid leukemia during pregnancy.
    Regierer AC; Schulz CO; Kuehnhardt D; Flath B; Possinger K
    Am J Hematol; 2006 Feb; 81(2):149-50. PubMed ID: 16432865
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effectiveness of interferon-alpha therapy in Ph-positive chronic myeloid leukemia].
    Bogdanov KV; Frolova OI; Marinets OV; Ogorodnikova IuS; Afanas'ev BV; Zaritskiĭ AIu
    Vopr Onkol; 2003; 49(2):189-92. PubMed ID: 12785203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myeloid leukaemia.
    Galesic K; Bozic B; Racic I; Scukanec-Spoljar M
    Nephrology (Carlton); 2006 Feb; 11(1):49-52. PubMed ID: 16509932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon therapy in chronic myelogenous leukemia.
    Guilhot F; Roy L; Guilhot J; Millot F
    Hematol Oncol Clin North Am; 2004 Jun; 18(3):585-603, viii. PubMed ID: 15271394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of interferon-alpha in chronic myeloid leukemia.
    Kumar L; Basade M; Gulati SC
    J Assoc Physicians India; 1995; Suppl 3():26-32. PubMed ID: 8773119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.